(Q38178543)

30 August 2017

title

Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome (English)

1 reference

30 August 2017

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Massimo Bellini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Corrado Blandizzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Stefano Milani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

G Bassotti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

15 January 2014

1 reference

Techniques in Coloproctology

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

613-621

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24425100%20AND%20SRC:MED&resulttype=core&format=json

Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Fundamentals of neurogastroenterology: basic science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Identification of cells that express 5-hydroxytryptamine1A receptors in the nervous systems of the bowel and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Serotonin receptors in the human brain--III. Autoradiographic mapping of serotonin-1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Mast cell expression of the serotonin1A receptor in guinea pig and human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

A proposed new nomenclature for 5-HT receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Mechanisms of action of the 5-HT1B/1D receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The distribution of 5-HT1D and 5-HT1E binding sites in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Actions of the 5-hydroxytryptamine 1 receptor agonist sumatriptan on interdigestive gastrointestinal motility in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Molecular biology of 5-HT receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The 5-HT3 receptor as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Gut pacemaker cells: the interstitial cells of Cajal (ICC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Serotonin Augments Gut Pacemaker Activity via 5-HT3 Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Differential modulation of the 5-HT(4) receptor agonists and antagonist on rat learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-HT(4) receptors, a place in the sun: act two.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Age and sex effects on 5-HT(4) receptors in the human brain: a [(11)C]SB207145 PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-Hydroxytryptamine stimulates human isolated atrium but not ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Distribution of the 5-HT5A serotonin receptor mRNA in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Human 5-HT(5) receptors: the 5-HT(5A) receptor is functional but the 5-HT(5B) receptor was lost during mammalian evolution

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

21 January 2018

12 December 2020

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

1 reference

5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Neurochemical bases of visceral nociception: mathematical model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Afferent pain pathways: a neuroanatomical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Visceral hypersensitivity: facts, speculations, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Decreased levels of kynurenic acid in the intestinal mucosa of IBS patients: relation to serotonin and psychological state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Neuroendocrine markers and psychological features in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Epidemiological aspects of irritable bowel syndrome in Europe and North America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Sex differences of brain serotonin synthesis in patients with irritable bowel syndrome using alpha-[11C]methyl-L-tryptophan, positron emission tomography and statistical parametric mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The relationship between somatisation and outcome in patients with severe irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Basic pathophysiologic mechanisms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Subtypes of constipation predominant irritable bowel syndrome based on rectal perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Bad news from the brain: descending 5-HT pathways that control spinal pain processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Irritable bowel syndrome: new agents targeting serotonin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Review article: tegaserod

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

Localization of 5-ht5A receptor-like immunoreactivity in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1106-8

BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats

21 January 2018

1 reference

12 December 2020

Autoregulation of serotonin neurons: role in antidepressant drug action

1 reference

12 December 2020

Central processing of rectal pain: a functional MR imaging study

1 reference

12 December 2020

Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype

1 reference

12 December 2020

Expression of mRNA for the serotonin 5-hydroxytryptamine1D beta receptor subtype in human and bovine cerebral arteries

1 reference

12 December 2020

Characterization of the human 5-hydroxytryptamine1B receptor

1 reference

12 December 2020

CGRP as a transmitter in the sensory pathway mediating peristaltic reflex

1 reference

12 December 2020

Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel

1 reference

12 December 2020

The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of 5-HT and its release in relation to intraluminal pressure and propulsive activity

1 reference

12 December 2020

Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist

1 reference

12 December 2020

Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat

1 reference

12 December 2020

Serotonin: a mediator of the brain-gut connection

1 reference

12 December 2020

Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation

1 reference

12 December 2020

Molecular cloning of a human serotonin receptor (S12) with a pharmacological profile resembling that of the 5-HT1D subtype

1 reference

12 December 2020

Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans

1 reference

12 December 2020

5-HT receptors mediating contractions of the isolated human coronary artery

1 reference

12 December 2020

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

1 reference

12 December 2020

Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients

1 reference

12 December 2020

Serotonin and its implication for the management of irritable bowel syndrome.

1 reference

12 December 2020

Rectal hypersensitivity in the irritable bowel syndrome

1 reference

12 December 2020

Serotonin receptor activation of phosphoinositide turnover in uterine, fundal, vascular, and tracheal smooth muscle

1 reference

12 December 2020

Cloning and functional characterization of the rat stomach fundus serotonin receptor

1 reference

12 December 2020

In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors

1 reference

12 December 2020

Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers

1 reference

12 December 2020

The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family

1 reference

12 December 2020

Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus

1 reference

12 December 2020

The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation

1 reference

12 December 2020

Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron)

1 reference

12 December 2020